NGM Biopharmaceuticals, Inc. Soared
Thu, Oct 20, 2022 at 07:09 PM
NGM Biopharmaceuticals, Inc. (NGM:NASDAQ) rocketted at $4.49, representing a gain of 21.7%. The stock got featured on our News Catalysts scanner on Mon, Oct 17, 2022 at 03:14 PM in the 'BIOTECH' category. From Thu, Oct 06, 2022, the stock recorded 40.00% Up Days and 45.45% Green Days
About NGM Biopharmaceuticals, Inc. (NGM:NASDAQ)
NGM Biopharmaceuticals Inc is a clinical-stage bio-pharmaceutical company. It is engaged in developing novel therapeutics based on scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic and ophthalmic diseases.
Top 10 Gainers:
- NextPlay Technologies Inc. (NXTP:NASDAQ), 107.31%
- Quanergy Systems Inc. (QNGY:NYSE), 51.2%
- Cabaletta Bio, Inc. (CABA:NASDAQ), 50.77%
- Save Foods Inc. (SVFD:NASDAQ), 31.33%
- Pineapple Holdings Inc Com (PEGY:NASDAQ), 29.74%
- Creatd Inc. (CRTD:NASDAQ), 28.97%
- Katapult Holdings Inc. (KPLT:NASDAQ), 24.31%
- VolitionRx Limited (VNRX:NYSEMKT), 22.76%
- NGM Biopharmaceuticals, Inc. (NGM:NASDAQ), 21.68%
- Skillz Inc. Class A (SKLZ:NYSE), 21.47%